CSIMarket Company Name, Ticker, Suppliers, else..
 
Amneal Pharmaceuticals Inc   (AMRX)
Other Ticker:  
 
 

AMRX's vs. Market share relative to its competitors, as of Q1 2024

As of Q1 2024 (Revenue in Millions of $)

Date modified: 2024-09-07T19:24:33+00:00



COMPANY NAME REVENUES
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months
Q1 2024		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE
A Quarter Before
Q4 2023
Amneal Pharmaceuticals Inc 2,495.44 13.27% 13.65 % 13.91 %
Agile Therapeutics Inc 19.72 0.10% 0.11% 0.11%
Teva Pharmaceutical Industries Limited 16,289.00 86.62% 86.24% 85.98%
SUBTOTAL 18,804.16 100% 4,828.14 100%



AMRX's vs. Market share relative to its competitors, as of Q1 2024 within the Major Pharmaceutical Preparations Industry
As of Q1 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months Ending
Q4 2023		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE

Q4 2023
Amneal Pharmaceuticals Inc 13.27% 13.00% 13.65 % 13.91 %
Agile Therapeutics Inc 0.10% 0.11% 0.11% 0.11%
Teva Pharmaceutical Industries Limited 86.62% 86.90% 86.24% 85.98%
SUBTOTAL 100% 100% 100% 100%



AMRX's vs. Market share relative to its competitors, as of Q1 2024 within the Healthcare Sector
As of Q1 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months Ending
Q4 2023		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE

Q4 2023
Amneal Pharmaceuticals Inc 13.27% 13.00% 13.65 % 13.91 %
Agile Therapeutics Inc 0.10% 0.11% 0.11% 0.11%
Teva Pharmaceutical Industries Limited 86.62% 86.90% 86.24% 85.98%
SUBTOTAL 100% 100% 100% 100%


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com